Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Wik

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomasHenrica M J Werner, Anna Berg, Elisabeth Wik, et al.
Oncotarget|April 11, 2015
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancerIngunn M Stefansson, Maria Raeder, Elisabeth Wik, et al.
Scientific Reports|January 17, 2026
Low tumoral Trefoil Factor 1 expression relates to aggressive tumor features and poor survival in young women with breast cancerAmalie B Kvamme, Ulrikke Hugaas, Anna K M Sæle, et al.
Oncotarget|March 25, 2014
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver geneErling A Hoivik, Kanthida Kusonmano, Mari K Halle, et al.
Scientific Reports|February 21, 2020
Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroupsCecilie Askeland, Elisabeth Wik, Kenneth Finne, et al.
Plos One|January 10, 2013
High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutatedCamilla Krakstad, Even Birkeland, Danila Seidel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2013
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trialJone Trovik, Elisabeth Wik, Henrica M J Werner, et al.
Plos One|December 3, 2015
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's CancersThomas E Bartlett, Allison Jones, Ellen L Goode, et al.
The Journal of Pathology. Clinical Research|September 30, 2025
Reduced GATA3 expression associates with immuno-metabolic alterations and aggressive features in breast cancerAnna Km Sæle, Amalie A Svanøe, Cecilie Askeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinomaElisabeth Wik, Maria B Ræder, Camilla Krakstad, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomasHenrica M J Werner, Anna Berg, Elisabeth Wik, et al.
Oncotarget|April 11, 2015
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancerIngunn M Stefansson, Maria Raeder, Elisabeth Wik, et al.
Scientific Reports|January 17, 2026
Low tumoral Trefoil Factor 1 expression relates to aggressive tumor features and poor survival in young women with breast cancerAmalie B Kvamme, Ulrikke Hugaas, Anna K M Sæle, et al.
Oncotarget|March 25, 2014
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver geneErling A Hoivik, Kanthida Kusonmano, Mari K Halle, et al.
Scientific Reports|February 21, 2020
Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroupsCecilie Askeland, Elisabeth Wik, Kenneth Finne, et al.
Plos One|January 10, 2013
High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutatedCamilla Krakstad, Even Birkeland, Danila Seidel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2013
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trialJone Trovik, Elisabeth Wik, Henrica M J Werner, et al.
Plos One|December 3, 2015
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's CancersThomas E Bartlett, Allison Jones, Ellen L Goode, et al.
The Journal of Pathology. Clinical Research|September 30, 2025
Reduced GATA3 expression associates with immuno-metabolic alterations and aggressive features in breast cancerAnna Km Sæle, Amalie A Svanøe, Cecilie Askeland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinomaElisabeth Wik, Maria B Ræder, Camilla Krakstad, et al.
Pageof 7